Drugs from Eli Lilly and Boehringer Ingelheim grabbed the spotlight at the EASL congress on liver diseases, both showing promising results in metabolic dysfunction-associated steatohepatitis (MASH).
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Anne Hathaway’s use of “inshallah” in a recent interview promoting The Devil Wears Prada 2 has gone viral for how naturally she used the phrase while reflecting on her life and career. The moment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results